X0407 4 2023-05-12 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001669737 Dahan Michel C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET CAMBRIDGE MA 02142 false true false false SVP, Chief Operating Officer false Common Stock 2023-05-12 4 A false 200000.00 0.00 A 469515.00 D The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. /s/ Carolyn Rucci, attorney-in-fact for Michel Dahan 2023-05-16